Abbott Laboratories (FRA:ABL) FFO


FRA:ABL Abbott Laboratories FRA:ABL
80 GF Score
Price €82.24
GF Value €114.21
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

FRA:ABL
80GF Score
Abbott Laboratories FRA:ABL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abbott Laboratories (FRA:ABL) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of €82.24 is trading 28% below its estimated GF Value™ of €114.21. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:ABL:

  • FFO:
  • GF Value™: €114.21 vs. price of €82.24 (28% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the FRA:ABL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for FRA:ABL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€82.24
Price
€114.21
GF Value